Fideicomiso Irrevocable F/2061 FHipo
BNZIF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -43.9% | 12.7% | -16% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 99.8% | 99.9% | 99.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $4 | $3 | $3 |
| SG&A Expenses | $0 | $0 | $3 | $3 |
| Sales & Mktg Exp. | $0 | -$4 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | -$0 | -$0 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 53.3% | 106.8% | 100.7% | 105.7% |
| Other Income/Exp. Net | $0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 54.6% | 55.9% | 66.4% | 43.8% |
| EPS | 0.066 | 0.15 | 0.12 | 0.096 |
| % Growth | -56% | 25% | 25.1% | – |
| EPS Diluted | 0.066 | 0.15 | 0.12 | 0.096 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $17 | $12 | $7 |
| Interest Expense | $0 | $14 | $10 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 121.4% | 107% | 109.8% | 124.2% |